Stay updated on VVIP in Relapsed Lymphoid Malignancies Clinical Trial

Sign up to get notified when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The NIH transition announcement banner is no longer displayed, while the page remains a 403 error page.
    Difference
    1%
    Check dated 2026-11-10T14:58:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T15:54:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The 403 Forbidden message and its Home button are no longer displayed, leaving the study-record page body blank beneath the breadcrumb.
    Difference
    0.5%
    Check dated 2026-10-27T14:45:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov error page. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:35:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:09:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page instead of the usual study record content. This blocks access to the trial details and related documents, altering how users can interact with the page.
    Difference
    24%
    Check dated 2026-09-22T22:26:37.000Z thumbnail image

Stay in the know with updates to VVIP in Relapsed Lymphoid Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VVIP in Relapsed Lymphoid Malignancies Clinical Trial page.